Inulite Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 04-07-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.74 Cr
as on 04-07-2024
- Revenue -83.51%
(FY 2021)
- Profit -1112.66%
(FY 2021)
- Ebitda -1121.75%
(FY 2021)
- Net Worth -217.55%
(FY 2021)
- Total Assets 6.28%
(FY 2021)
About Inulite Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹4.74 Cr.
Dinesh Jain, Amitava Pathak, Kanwar Singh, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24290CH2016PTC041114
- Company No.
041114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Inulite Nutraceuticals Private Limited offer?
Inulite Nutraceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Digestive Drugs.
Who are the key members and board of directors at Inulite Nutraceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Garg  | Director | 29-Jun-2016 | Current |
| Kanwar Singh | Director | 29-Jun-2016 | Current |
| Dinesh Jain | Director | Current | |
| Amitava Pathak | Director | 01-Feb-2018 | Current |
| Madhu Goyal | Director | 29-Jun-2016 | Current |
| Rajeshwar Rana | Director | 29-Jun-2016 | Current |
Financial Performance and Corporate Structure Insights of Inulite Nutraceuticals.
Inulite Nutraceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 83.51% decrease. The company also saw a substantial fall in profitability, with a 1112.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 217.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inulite Nutraceuticals?
In 2021, Inulite Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sri Padaam Naabh Food Industries Private LimitedActive 12 years 11 months
Kanwar Singh, Madhu Goyal and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Sep 2020 | ₹6.20 M | Open |
Others Creation Date: 03 May 2018 | ₹4.12 Cr | Open |
How Many Employees Work at Inulite Nutraceuticals?
Unlock and access historical data on people associated with Inulite Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inulite Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inulite Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
